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The treatment outcome literature suggests that alcoholics with co- 
existing drug dependence have worse prognoses. We compared 
three groups of inpatients treated on the same hospital unit for 
disorders of alcohol only (n  = 51), cocaine only (n  = 27), or both 
disorders (dual group, n = 27). At follow-up, we contacted 105 (8lY0) 
of 129 patients at a mean of 13.4 & 4.1 months after discharge. The 
three groups significantly and equivalently decreased their con- 
sumption of substances at follow-up, and they also had equivalent 
improvements in employment and in medical and psychiatric well- 
being. A nonsignificant trend existed for greater abstinence in the 
alcohol group (53%) than in the dual group (SSYO), and with regres- 
sion analysis diagnostic group and stable residence predicted ab- 
stinence in the past 30 days. Elapsed time before using alcohol was 
equivalent for the two alcohol groups, and relapse to alcohol pre- 
ceded relapse to cocaine by 1 month on average. In sum, outcomes 
were more similar than different for the three groups. Although 
specific treatments to enhance abstinence for cocaine users are 
indicated, clinicians should approach cocaine-using alcoholics with 
equal optimism for improvement as with other alcoholics. 
Key Words: Treatment Outcome, Alcoholism, Cocaine, Substance 
Abuse, Residential Treatment. 
EW STUDIES HAVE specifically compared the out- F comes of alcoholic patients with and without coexisting 
cocaine disorders. Miller and colleagues’ compared the 
outcomes of inpatients with either alcohol dependence 
alone or cocaine dependence (of which 94% also had 
alcohol dependence). At 12 months, current abstinence 
rates for alcohol and other drugs, respectively, were lower 
in the cocaine group (62% and 66%) than in the alcohol 
group (7 1 % and 96%), but statistical analyses and psycho- 
social outcomes were not reported. Walsh and colleagues2 
found that cocaine-using alcohol abusers were significantly 
more impaired than others at a 2-year follow-up assess- 
ment. More recently, Carroll and colleagues3 reported that 
concurrent alcoholism worsened the prognoses of 94 
treated cocaine abusers across multiple outcome dimen- 
sions, but they did not study an alcohol-only group. 
The purpose of this study was to compare the treatment 
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outcomes of alcoholics with and without coexisting co- 
caine disorders in terms of hospital course, substance use, 
employment, medical problems, psychiatric symptoms, 
and further treatment. We hypothesized that cocaine- 
disordered alcoholics have worse prognoses than other 
alcoholics. We also included a comparison group of pa- 
tients with cocaine disorders only. 
METHODS 
The study was conducted after obtaining approval from the Human 
Subjects Committee at the University of Michigan Medical Center. 
Subjects 
We conducted a computer search of discharge diagnoses for inpatients 
who were consecutively discharged between December 1986 and January 
1988 from the University of Michigan alcohol and drug treatment unit. 
Our search yielded 139 cases whose discharge diagnoses fit into one of 
the following three groups: ( I )  alcohol abuse or dependence only (alcohol 
group), (2) cocaine abuse or dependence only (cocaine group), or (3) 
both an alcohol and cocaine disorder (“dual” group). Discharge diagnoses 
were clinically determined by the consensus of an attending (K.J.B.) and 
a resident psychiatrist using the DSM-111 criteria‘ before June 1987 and 
the DSM-111-R criteria5 starting in June 1987. Of the 139 cases identified 
by computer, we were able to locate I30 hospital charts for a retrospective 
chart review. 
As a further check on group assignment, we searched for patients in 
the cocaine-only group who had blood alcohol levels >5 mg/100 ml on 
admission (n = 0) and for patients from the alcohol-only group who had 
positive urine drug screens for cocaine at the time of admission (n = 4). 
Blood alcohol levels were determined by a breath testing device for which 
readings at or below 5 mg/ 100 ml were clinically disregarded, because of 
the sensitivity of the instrument. Three of the cases with positive urines 
for cocaine were reassigned to the dual group, because chart reviews 
revealed a cocaine disorder. The other case was excluded from the study, 
because the data were insufficient to rule out a cocaine disorder. After 
refining the groups, no cases in the alcohol-only group had a positive 
urine test for cocaine. 
Of the 129 remaining cases, we were able to contact 105 patients 
(81.4% of 129) for a follow-up interview. Of the 24 patients whom we 
did not interview, 5 were contacted but refused to participate and 19 
were lost to follow-up. We compared the 105 patients who consented to 
a follow-up interview and the 24 unavailable patients in terms of diag- 
nostic group, age, gender, race, education, employment, marital status, 
prior treatment, ages at first use of alcohol and cocaine, durations of 
problematic alcohol and cocaine use, quantities and frequencies of 
alcohol and cocaine use, medical problems, and psychiatric symptoms. 
Of 19 comparisons, one significant difference was found. For cocaine 
users, “followed” patients (mean = 23.8 f 7.2 years) were significantly 
older than nonfollowed patients (mean = 18.9 f 6.6) when they first 
used cocaine ( t  = -2.06, df = 58, p = 0.043). Importantly, the three 
diagnostic groups contained equivalent proportions.of patients who were 
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followed ( x 2  = 0.29, d f =  2, p = 0.865). Altogether, we contacted 51 
patients in the alcohol group, 27 patients in the cocaine group, and 21 
patients in the dual group. 
Data Cotiection 
Baseline (tl) characteristics of patients were determined by a retro- 
spective chart review. One reviewer recorded pertinent information from 
each medical chart onto a structured form that allowed for easy coding 
and computer entry. Patients were rated as having medical problems if 
the chart review indicated alcohol-related health problems (such as 
cirrhosis, pancreatitis, or convulsions) or cocaine-related health problems 
(such as heart attacks, arrhythmias, strokes, or convulsions). Psychiatric 
problems were determined from the history and mental status exam as 
conducted by a psychiatry resident for each patient. A psychiatric severity 
score (range 0-10) was calculated as the sum of 10 items: serious 
depression; serious anxiety or tension; hallucinations; trouble under- 
standing, concentrating, or remembering; trouble controlling violent 
temper; thoughts of suicide; attempted suicide; prior treatments for 
psychological or emotional problems; receiving a psychiatric disability; 
and medications previously prescribed for a psychiatric problem. 
Follow-up (t2) data were obtained 6-23 months after discharge (mean 
= 13.4 f 4.1 months) by a structured telephone interview, which we 
designed for this study. Subjects were told the purpose of the telephone 
call, given assurance about confidentiality, and then asked if the inter- 
viewer could proceed, all according to a written script. An affirmative 
response constituted verbal consent to participate in the study. Subjects 
were read 86 questions that required either yes-no responses, numerical 
answers, or multiple choice responses. The questions in the telephone 
interview were patterned as much as possible after the baseline (tl) data 
recorded from the chart review. Thus, responses required minimal inter- 
pretation, were easily coded, and were readily comparable to the baseline 
(11) data. Interviews were completed in 30 min on average. We used two 
telephone interviewers, one medical student, and one research nurse who 
were closely supervised by a psychiatrist (K.J.B.), but we did not deter- 
mine interrater reliability. Although the validity of the telephone inter- 
view was not corroborated by a collateral informant or body fluid 
analysis, interviewers rated their own confidence in the validity of the 
information obtained. Overall, the interviewers rated 76.7% of the inter- 
views with confidence, and the three diagnostic groups did not differ in 
their confidence ratings ( x 2  = 1.80, df= 2, p = 0.407). 
Treatment 
All patients were treated on the same inpatient treatment unit for 
detoxification and rehabilitation. Patients attended the same program 
activities together as a group, regardless of diagnosis. Completed treat- 
ment averaged between 2 and 3 weeks, and consisted of lectures, individ- 
ual and group therapy, relapse prevention counseling, activity therapy, 
and attendance at 12-step groups. Family and significant others were 
encouraged to attend both an education group and an individual family 
session. Medications were not prescribed for substance dependence, 
except benzodiazepines as needed for alcohol withdrawal. An aftercare 
plan was developed for each patient before a regular discharge. 
Data Analysis 
At baseline ( t l )  we compared groups using likelihood ratio x2 tests for 
categorical variables and analyses of variance (ANOVAs) for continuous 
variables. If the three groups differed, then we ran contrasts between the 
alcohol and dual groups, and between the dual and cocaine groups. We 
used t tests when only two groups were compared on continuous vari- 
ables, and a Fisher’s exact test if cell sizes were too small for valid x2 
testing. Similar tests were used at t2 for treatment utilization. All tests 
were two-tailed. For each t l  variable that differed significantly among 
groups, we determined its effect on, or correlation with, three major 
outcome variables: total abstinence, past 30-days abstinence, and psy- 
chiatric severity. Only age differed among groups at t 1 and also differed 
between patients who did and did not remain abstinent. Thus, age was 
entered as a covariate or as a predictor variable in our t 142 comparisons. 
Most of the primary outcome measures were skewed, because many 
patients consumed no substances at follow-up. For continuous variables, 
therefore, difference scores (t2 - t l )  were analyzed instead of using 
repeated measures ANOVAs, which assume normally distributed scores. 
Analyses of continuous variables were conducted in two steps. First, a 
time effect was determined using a t test; i.e., did the mean difference 
score differ significantly from O? This test was equivalent to a paired t 
test. Second, analyses of covariance were used to test group differences 
in change over time while covarying for age. For categorical (yes-no) 
variables, change codes (analogous to difference scores) were constructed, 
resulting in three possible outcomes over time: a positive change, no 
change, or a negative change. Then logistic regression analyses were used 
to test if diagnostic group and age predicted the three change categories. 
Finally, we used stepwise multiple regression techniques to determine 
the best predictors of abstinence for the two alcohol groups. 
RESULTS 
Baseline Characteristics (t l)  
Demographic Characteristics. The three groups differed 
in age and race, but did not differ in gender, employment, 
married status, or education (Table 1). The alcohol group 
(mean = 37 years) was significantly older than the dual 
group (mean = 31 years) and had more whites (90% vs. 
52%). More than twice as many individuals in the alcohol 
group (28%) as in the dual group (1  1 %) lived alone, but 
the difference was not significant (x2 = 3.16, df= 1, p = 
0.075). Indices of social stability did not differ between 
groups. Overall, 60% of the sample had a stable residence, 
and 25% had a stable job over the 6 months before 
admission. 
Substance Use. The alcohol and dual groups did not 
differ in age of first alcohol use (mean = 14.6 years), nor 
did they differ in the duration of problematic alcohol use 
(mean = 8.9 years). They also did not differ in terms of 
their frequency or quantity of drinking (Fig. 1). Likewise, 
the cocaine and dual groups did not differ in age of first 
cocaine use (mean = 23.8 years), in the duration of 
problematic cocaine use (mean = 2.0 years), or in the 
frequency or quantity of cocaine use (Table 1 and Fig. 2). 
Similar proportions of the cocaine (85%) and dual users 
(74%) smoked crack cocaine as their preferred mode of 
use (x2 = 1.04, df = 1, p = 0.308). Significantly more 
individuals in the alcohol group (6 1 %) than the dual group 
(30%) received prior treatment for substance disorders, 
but the dual and cocaine (33%) groups did not differ 
significantly (Table 1). 
The dual group (63%) was significantly more likely than 
the alcohol (8%) and cocaine (7%) groups to have coexist- 
ing cannabis abuse or dependence (x2 = 35.82, df = 2, p 
< 0.00 1). No other substance diagnoses distinguished the 
three groups, which had the following frequencies (abuse 
and dependence combined): sedative-hypnotics (4%), am- 
phetamine (2%), opioids (1 %), hallucinogens, phencycli- 
dine, or inhalants (0%). Urine testing confirmed the di- 
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Table 1. Pretreatment Characteristics 
Alcohol Dual Cocaine Alcohol vs. Dual vs. 
group group group dual p cocaine p 
Variable (n = 51)’ (n  = 27)’ (n = 27)’ valuet valuet 
Demographic variables 
Age ( Y ~ H  36 8 f 14.1 30.5 f 7.9 26.8 f 5.4 0.018 0.220 
O h  Male 66.7 66.7 59.3 NS NS 
O h  White 90.2 51.8 33.3 (0.001 0.167 
Education (yr)* 12.8 f 2.5 11.8+ 1.9 11.9f 1.3 NS NS 
% Employed 29.4 44.4 25.9 NS NS 
Stable job for 6 mos ( O h )  23.5 37.0 14.0 NS NS 
% Living alone 28.0 11.1 0 0.075 0.2368 
% Married 15.7 11.1 7.4 NS§ NS§ 
Stable residence for 6 mos (Yo) 62.0 62.5 52.0 NS NS 
Substance use 
Age at 1st alcohol use* (yr) 14.5 f 4.0 14.6 f 4.3 NAn NS -n 
Duration of problem alcohol 9.0 f 7.2 0.7 f 6.8 NAY NS -11 
u s *  (YO 
use$ (YO 
Age at 1 st cocaine use$ (yr) NAY 24.6 f 8.2 23.2 f 6.4 -!I NS 
Duration of problem cocaine NAY 2.3 f 3.2 1.7 f 1.4 -n NS 
Prior substance treatment ( O h )  60.8 29.6 33.3 0.008 0.769 
* Sample sizes may be smaller for some comparisons due to missing values. 
t If overall p value for comparing the three groups was significant, then p values for the contrasts are shown. If overall p value for three groups was not significant, 
$ Mean f SD. 
5 Fisher’s exact test was used. 
ll Comparison not applicable. 
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Fig. 2. Cocaine consumption before and after treatment by diagnostic group. 
Before After 
Treatment Treatment 
(tl)  (t2) 
Fig. 1. Alcohol consumption before and after treatment by diagnostic group. 
agnostic similarities and differences between the three 
groups. 
Medical and Psychiatric Status. The alcohol (23.5%) 
and dual (14.8%) groups did not differ in the proportion 
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with alcohol-related health problems (x2 = 0.82, df= 1 ,  p 
= 0.355). Similarly, the dual (25.9%) and cocaine (29.6%) 
groups did not differ in the proportion with cocaine- 
related health problems (x2 = 0.09, df = 1 ,  p = 0.761). 
The three groups differed significantly on psychiatric se- 
verity ( F  = 3.96, df = 104, p = 0.022), with the alcohol 
group having the most severity (mean = 3.2 f 1.9) and 
the cocaine group having the least severity (mean = 2.0 f 
1.8). However, contrasts with the dual group (mean = 2.7 
f 2.1) were not significant. 
Hospital Course. The three groups did not differ in the 
percentage completing the program with a regular dis- 
charge (73%), mean length of stay (16.6 days), or the 
percentage who had family or friends attend treatment 
programming (79%) (Table 2). 
Follow- Up Ratings (t2) 
Follow-up durations differed significantly between the 
dual (mean = 15.1 f 4.6 months) and cocaine (mean = 
11.5 f 3.2 months) groups (t  = -3.42, df = 53, p = 0.001). 
Because the groups also differed at t l  in age, race, living 
situation, prior treatment, cannabis abuse, and psychiatric 
severity, we looked for correlations or effects of each of 
these variables on abstinence measures and psychiatric 
severity at t2. We did not find that follow-up durations 
differed between those who remained abstinent and those 
who did not (t  = 0.42, df = 103, p = 0.674). Not surpris- 
ingly, we found that psychiatric severity at t l  correlated 
significantly with psychiatric severity at t2 (rs = 0.37, df = 
104, p < 0.001). The only other significant difference was 
that individuals who remained abstinent throughout the 
follow-up duration were significantly older (mean = 38.9 
f 14.8 years) than those with any use (mean = 30.4 f 
9.5) ( t  = -3.46, df = 35, p = 0.008 for unequal variances). 
Thus, we used age as a covariate in our analyses of change 
over time. 
Substance Use. Both the alcohol and dual groups had 
Table 2. Treatment Utilization' 
Alcohol group Dual group Cocaine roup 
Variable (n = 51)t (n = 27)t (n = 2Q)t 
Hospital course (t 1) 
Completed program (%) 76.5 77.8 63.0 
Length of stay* (days) 17.3 * 7.2 17.4 f 7.6 14.6 f 5.7 
Family or friends attend pro- 76.5 74.1 88.9 
gram (%) 
Treatment utilization (t2) 
Attended inpatient treatment 4.0 4.0 3.8 
after discharge (YO) 
in last 30 days (YO) 
tended in last 30 days* 
tended in 1 week since dis- 
charge (no.)$ 
Attended outpatient treatment 20.4 4.0 7.4 
No. of 12-step meetings at- 5.3 * 8.6 4.3 * 9.3 2.1 f 6.8 
Most 12-step meetings at- 5.0 & 5.4 3.9 f 4.6 3.0 * 3.4 
None of the comparisons between the alcohol and dual groups, or between 
t Sample sizes may be smaller for some comparisons due to missing values. 
$ Mean * SO. 
the dual and cocaine groups were significant. 
significantly and equivalently reduced their frequency and 
quantity of drinking at follow-up (Fig. 1). The mean 
reduction in drinking days over time was significant ( t  = 
9.42, df = 63, p < 0.001), as was the mean reduction in 
drinks/day (t = 9.24, df = 60, p < 0.001). After covarying 
for age, the patients in the two groups did not differ in 
their reduction of either quantity ( F  = 0.00, df = 1 ,  p = 
0.978) or frequency ( F  = 0.08, df = 1 ,  p = 0.773) of 
drinking. Likewise, both the dual group and cocaine group 
had significantly and equivalently reduced their frequency 
and quantity of cocaine use at follow-up (Fig. 2). The 
mean reduction in cocaine-using days over time was sig- 
nificant (t = 7.71, df = 42, p c 0.001), as was the mean 
reduction in g of cocaine used/day (t  = 4.73, df = 39, p < 
0.001). After covarying for age, the patients in the two 
groups did not differ in their reduction of either quantity 
( F  = 2.91, df = 1,  p = 0.096) or frequency ( F  = 0.22, df 
= 1 ,  p = 0.644) of cocaine use. 
Abstinence rates revealed that 33.3% of the alcohol 
group and 15.4% of the dual group remained alcohol-free 
for the entire follow-up period (x2 = 2.99, df = 1 ,  p = 
0.084). For the 30 days before follow-up, 52.9% of the 
alcohol group and 42.3% of the dual group remained 
alcohol-free (x2 = 0.78, df = 1,  p = 0.377). Forty percent 
of the dual group and 29.6% of the cocaine group re- 
mained cocaine-free for the full follow-up period (x2 = 
0.62, df = 1 ,  p = 0.432), and 66.7% of the dual group and 
77.8% of the cocaine group remained cocaine-free for the 
30 days before follow-up (x2 = 0.78, df = 1 ,  p = 0.375). 
To compare abstinence rates among all three groups si- 
multaneously, we compared abstinence from alcohol in 
the alcohol group with abstinence from cocaine in the 
cocaine group and abstinence from both alcohol and 
cocaine in the dual group. For the entire follow-up period, 
the alcohol group (33.3%) had three times the abstinence 
rate of the dual group ( 1  1 . 1 % )  compared with 29.6% for 
the cocaine group (x2 = 5.20, df = 2, p = 0.074). For the 
30 days before follow-up, the cocaine group had a higher 
rate of abstinence (77.8%) than the alcohol (52.9%) and 
dual (34.6%) groups (x2 = 10.5, df = 2, p = 0.005), but 
only the contrast between the cocaine and dual groups 
was significant. For patients in the alcohol and dual groups 
who used alcohol after discharge, no significant difference 
was found between the mean intervals before resuming 
alcohol use (Fig. 3). Likewise, the dual and cocaine groups 
did not differ in the mean time to resumed cocaine use 
(Fig. 3). 
Employment, Medical, and Psychiatric Status. The 
three groups did not differ in employment, medical, or 
psychiatric status at follow-up. More patients were em- 
ployed at follow-up than at baseline, and fewer patients 
suffered with substance-related health problems at t2 than 
at t 1 (Table 3). Neither diagnostic group nor age predicted 
changes in employment or health problems by logistic 
regression analyses. The mean reduction in psychiatric 
severity scores over time (mean = 0.6 f 2.2) differed 
738 
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DISCUSSION 1 I 
_ .  
Alcohol Dual Dual Cocaine 
Group Grwp Group Grwp 
Relapse to Alcohol Relapse to Cocaine 
t=-0.89, df=27.8, p=O.379 t=0.07, df=29, p=0.941 
Fig. 3. Rapidity of relapse to preferred substances for those who used by 
diagnostic groups. Means 2 1 SE are shown. Differences between each pair of 
groups were not significant. 
significantly from 0 ( t  = 2.93, df= 103, p = 0.004). After 
covarying for age, the difference between groups in reduc- 
tion of psychiatric seventy was not significant ( F  = 2.15, 
df= 2, p = 0.123). 
Treatment Utilization. The three groups did not differ 
in their use of inpatient treatment for substance abuse 
after discharge (4.0% of sample) (Table 2). Five times as 
many alcohol patients (20.4%) as dual patients (4.0%) 
attended outpatient treatment in the past 30 days, which 
approached significance (Fisher's exact test. p = 0.086). 
Finally, the three groups did not differ significantly in their 
current or maximum attendance at 12-step meetings 
(Table 2). 
Predictors of Abstinence for Alcohol Groups 
Because few differences between groups were found at 
t2, we hypothesized that factors other than diagnostic 
group may predict outcome better. In particular, substance 
~everi ty ,~,~ social ~tability,~ psychiatric ~everity,~*~.* and 
treatment compliance' have been shown to predict out- 
come in other studies. Thus, we used multiple regression 
techniques to examine which variables among the various 
domains (Table 4) best predicted abstinence in the past 30 
days for the alcohol and dual groups. The best predictors 
of abstinence were stable residence and diagnostic group, 
which correctly classified 72% of cases (goodness of fit x2 
= 9.54, df = 2, p = 0.008). 
All three groups significantly and equivalently decreased 
their consumption of substances at follow-up (Figs. 1 and 
2). All three groups also had equivalent improvements in 
employment status, substance-related health problems 
(Table 3), and psychiatric problems following treatment. 
The three groups did not differ significantly in terms of 
program completion rates, new treatment episodes, or 
attendance at 12-step meetings (Table 2). A nonsignificant 
trend existed for patients in the dual group to relapse at a 
higher rate than patients in the alcohol group. In addition, 
when regression techniques were used for the alcohol and 
dual groups, diagnostic group was a significant predictor 
of abstinence in the past 30 days. Among those who 
relapsed, however, no differences were found in how long 
it took to relapse (Fig. 3). Taken together, there were more 
similarities than differences in outcome for the three 
groups, but the dual group had a poorer prognosis when 
abstinence was used as the outcome measure. 
Our findings are consistent with two previous studies 
that reported worse outcomes for cocaine-using alcoholics 
than for other alcoholics when generic treatment ap- 
proaches were applied. ' J  Nevertheless, our cocaine users 
reported major improvements following treatment despite 
lower rates of abstinence. All of our cases were inpatients, 
and Walsh et a1.2 found that inpatient treatment was 
significantly more effective than assignment to either Al- 
coholics Anonymous (AA) alone or a choice of AA or 
inpatient treatment. Thus, clinicians should approach 
their inpatient cocaine-using alcoholics with the same 
optimism for improvement as with their other alcoholic 
inpatients, but specific programming for cocaine users 
may be needed to enhance abstinence. 
Relapse to alcohol use preceded relapse to cocaine use 
by 1 month on average for the dual group (Fig. 3). Cocaine 
users should be specifically educated about this pattern of 
relapse. Moreover, cocaine-using alcoholics should be 
monitored closely for the first 3-6 months following in- 
patient treatment, because relapse to cocaine occurred 
most commonly during this time frame (Fig. 3). However, 
cocaine-using alcoholics attended outpatient treatment at 
a much lower rate than the alcohol-only group (Table 2), 
so intensive efforts to engage them in follow-up treatment 
may be needed to prevent relapse. 
Several limitations apply to our study. First, we retro- 
spectively reviewed charts for baseline ( t l )  data. Informa- 
tion was sometimes missing, and other information may 
have been inconsistently recorded or interpreted by the 
Table 3. Employment and Medical Status Before and After Treatment 
Change outcomes' 
n Variable t l  22 Positive Negative No change 
% Employed 104 31.7 53.8 27.9 5.0 66.4 
Alcohol-related health problems (%) 75 21.3 9.3 14.7 2.7 82.7 
Cocaine-related health problems (%) 51 27.4 15.7 21.6 9.8 68.3 
Neither diagnostic group nor age predicted change outcomes by logistic regression analyses. 
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Table 4. Potential Predictors of Abstinence 
Domains Variables' 
Substance severity Diagnostic groupt 
Age at first alcohol use 
Duration of problematic alcohol use 
Frequency of use in past 30 days 
Drinks/day in past 30 days 
Cannabis disorder 
Stable employment for 6 mos 
Stable residence for 6 most 
Family or friends attend treatment 
Psychiatric severity score at t l  
Completed program with regular discharge 
Length of stay 




* Variables entered into stepwise multiple regression analysis. 
t Variables shown to predict abstinence in past 30 days for the alcohol and 
dual groups in final model. 
chart reviewer. Second, we relied solely on self-report for 
outcome data. Corroborating histories and body fluid 
analyses were not obtained at t2. Some patients may 
minimize or deny drinking. lo Nevertheless, research sug- 
gests that self-reported data in alcohol studies are not 
inherently invalid." In situations where confidentiality is 
assured and there are no negative consequences of telling 
the truth, validity is Moreover, the rates of 
abstinence reported by our alcoholic patients were com- 
parable to those reported elsewhere in the 1iterat~re.I~ 
Finally, confidence ratings in the reported information 
were high and did not differ among groups. Thus, even if 
patients minimized their substance use and problems at 
t2, we have no reason to believe the three groups differed 
in self-report bias. However, validity and sensitivity may 
have been further enhanced by using a time-line follow- 
back method for substance use" and a well-studied instru- 
ment such as the Addiction Severity IndexI4 for medical 
and psychiatric severity. Another limitation of our study 
was the small sample size, which may have prevented 
some differences between groups from reaching statistical 
significance. 
In conclusion, patients with alcohol and/or cocaine 
abuse and dependence responded favorably to the same 
inpatient treatment program when followed for an average 
of 1 year. Improvements in substance use, employment 
status, and medical and psychiatric well-being were re- 
ported. The alcohol group had higher rates of abstinence 
than the dual group. Further research is needed to develop 
specific treatments to improve outcomes for patients with 
both alcohol and cocaine disorders. 
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